324 related articles for article (PubMed ID: 14666649)
21. Four years experience of primary intra-arterial chemotherapy (PIAC) for locally advanced and recurrent breast cancer.
Cantore M; Fiorentini G; Cavazzini G; Molani L; Morandi C; Caforio M; Caleffi G; Mambrini A; Zamagni D; Smerieri F
Minerva Chir; 1997 Sep; 52(9):1077-82. PubMed ID: 9401355
[TBL] [Abstract][Full Text] [Related]
22. Dose-dense primary chemotherapy, as part of multidisciplinary treatment, for inoperable stage III B breast cancer--long-term results of a phase II trial.
Massidda B; Atzori F; Scanu A; Contu A; Farris A; Catino AM; Palmeri S; Minerba L; Ionta MT
Oncology; 2007; 72(1-2):17-26. PubMed ID: 17998786
[TBL] [Abstract][Full Text] [Related]
23. [Clinical evaluation of effects from neo-adjuvant chemotherapy with epirubicin plus paclitaxel in cases of locally advanced breast cancer].
Tong F; Zhou B; Yang D; Cao Y; Liu P; Liu H; Qiao X; Zhang J
Gan To Kagaku Ryoho; 2002 Jul; 29(7):1147-52. PubMed ID: 12145994
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant chemotherapy with vinorelbine-containing regimens in elderly patients with locally advanced breast cancer.
Ma CD; Chen CM; Chen XS; Liu GY; Di GH; Wu J; Lu JS; Yang WT; Chen JY; Shao ZM; Shen ZZ; Shen KW
Anticancer Res; 2008; 28(5B):3093-7. PubMed ID: 19031963
[TBL] [Abstract][Full Text] [Related]
25. Pathological and clinical response of a primary chemotherapy regimen combining vinorelbine, epirubicin, and paclitaxel as neoadjuvant treatment in patients with operable breast cancer.
Abrial C; Van Praagh I; Delva R; Leduc B; Fleury J; Gamelin E; Sillet-Bach I; Penault-Llorca F; Amat S; Chollet P
Oncologist; 2005 Apr; 10(4):242-9. PubMed ID: 15821244
[TBL] [Abstract][Full Text] [Related]
26. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
Bustová I
Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of epirubicin plus oxaliplatin and infusional 5-fluorouracil as first-line combination therapy in patients with metastatic or advanced gastric cancer.
Zhang CX; Huang S; Xu N; Fang JW; Shen P; Bao YH; Mou BH; Shi MG; Zhong XL; Xiong PJ
Anticancer Drugs; 2007 Jun; 18(5):581-6. PubMed ID: 17414627
[TBL] [Abstract][Full Text] [Related]
28. [Intra-arterial infusion chemotherapy for breast cancer].
Matsumoto Y; Terakado H; Ikawa M; Hamada E; Watanabe Y; Nakasato S; Takaki S; Murata M; Miura T
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1526-8. PubMed ID: 8854797
[TBL] [Abstract][Full Text] [Related]
29. Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumors.
Cantore M; Mambrini A; Fiorentini G; Rabbi C; Zamagni D; Caudana R; Pennucci C; Sanguinetti F; Lombardi M; Nicoli N
Cancer; 2005 Apr; 103(7):1402-7. PubMed ID: 15726542
[TBL] [Abstract][Full Text] [Related]
30. [A case of locally advanced breast cancer successfully treated with intra-arterial infusion chemotherapy of high-dose epirubicin].
Kim Y; Takatsuka Y; Hasegawa S; Kondou M; Hirao T; Kan K; Fukunaga M
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2119-22. PubMed ID: 9838916
[TBL] [Abstract][Full Text] [Related]
31. Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer: an analysis of results in clinical practice of the Gruppo Oncologico Italia Meridionale (GOIM).
Gebbia V; Caruso M; Borsellino N; Ajello R; Tirrito ML; Chiarenza M; Valenza R; Verderame F; Varvara F; Marrazzo A; Bajardi E; Ferrao F; Bordonaro R; Tralongo P
Anticancer Res; 2006; 26(4B):3143-50. PubMed ID: 16886648
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma.
Al-Amro A; Al-Rajhi N; Khafaga Y; Memon M; Al-Hebshi A; El-Enbabi A; El-Husseiny G; Radawi A; Belal A; Allam A; El-Sebaie M
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):508-13. PubMed ID: 15890594
[TBL] [Abstract][Full Text] [Related]
33. [A comparative study of intra-arterial infusion chemotherapy and systemic chemotherapy in the treatment of locally advanced breast cancer].
Takatsuka Y; Kawahara T; Yayoi E; Okamura J; Miyauchi K; Shiba E; Mori T
Gan To Kagaku Ryoho; 1991 Aug; 18(11):1740-3. PubMed ID: 1877813
[TBL] [Abstract][Full Text] [Related]
34. Neoadjuvant intra-arterial chemotherapy in locally advanced breast cancer: a prospective randomized study. Osaka Breast Cancer Study Group.
Takatsuka Y; Yayoi E; Kobayashi T; Aikawa T; Kotsuma Y
Jpn J Clin Oncol; 1994 Feb; 24(1):20-5. PubMed ID: 8126916
[TBL] [Abstract][Full Text] [Related]
35. Paclitaxel and epirubicin followed by cyclophosphamide, methotrexate and 5-fluorouracil for patients with stage IIIC breast cancer with ten or more involved axillary lymph nodes.
Battelli N; Massacesi C; Braconi C; Pilone A; Manzione L; Dinota A; Cobelli S; Scanni A; Sturba F; Giacomini G; Morale D; Giorgi F; Tummarello D; Cascinu S
Am J Clin Oncol; 2006 Aug; 29(4):380-4. PubMed ID: 16891866
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory breast cancer outcome with epirubicin-based induction and maintenance chemotherapy: ten-year results from the French Adjuvant Study Group GETIS 02 Trial.
Veyret C; Levy C; Chollet P; Merrouche Y; Roche H; Kerbrat P; Fumoleau P; Fargeot P; Clavere P; Chevallier B
Cancer; 2006 Dec; 107(11):2535-44. PubMed ID: 17054108
[TBL] [Abstract][Full Text] [Related]
37. 5-year results of cisplatin-epirubicin-vinorelbine (PEV) combination as primary chemotherapy in T2-3, N0-2 breast cancer patients: a multicentre phase II study.
Barni S; Visini M; Piazza E; Ionta MT; Ardizzoia A; Arnoldi E; Fava S; Pinotti G; Torretta F; Corradini G; Villa S; Nosenzo AM; Massidda B; Cazzaniga ME
Anticancer Res; 2007; 27(4C):3019-24. PubMed ID: 17695490
[TBL] [Abstract][Full Text] [Related]
38. Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel.
Torrisi R; Balduzzi A; Ghisini R; Rocca A; Bottiglieri L; Giovanardi F; Veronesi P; Luini A; Orlando L; Viale G; Goldhirsch A; Colleoni M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):667-72. PubMed ID: 18064460
[TBL] [Abstract][Full Text] [Related]
39. Randomized trial comparing neo-adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0-2 M0).
Deo SV; Bhutani M; Shukla NK; Raina V; Rath GK; Purkayasth J
J Surg Oncol; 2003 Dec; 84(4):192-7. PubMed ID: 14756429
[TBL] [Abstract][Full Text] [Related]
40. [Neoadjuvant intra-arterial infusion chemotherapy for the treatment of locally advanced breast cancer with remote metastases].
Nakagawa H; Takatsuka Y; Shin E; Mishima H; Tono T; Tamaki Y; Yagyu T; Kobayashi K; Kikkawa N
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2274-7. PubMed ID: 7944458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
